Dexcom (Nasdaq:DXCM) announced today that it launched its G6 continuous glucose monitor (CGM) mobile app in Spanish. San Diego-based Dexcom’s G6 mobile app in Spanish has been made available immediately for users with a compatible iOS (v1.10.1) or Android (v1.10.0) smart device. The company said in a news release that diabetes disproportionately impacts Latinos. As […]
Tandem Diabetes Care acquires infusion set maker Capillary Biomedical
Tandem Diabetes Care (Nasdaq:TNDM) announced that it acquired infusion set developer Capillary Biomedical. San Diego-based Tandem, a global insulin delivery and diabetes technology company, announced its intention to acquire Irvine, California-based Capillary last week. Financial terms for the deal were not disclosed. “Infusion sets provide people flexible options in insulin pump wearability, and we are […]
Fresenius Kabi launches Simplist Glycopyrrolate injection in U.S.
Fresenius Kabi announced today that its Glycopyrrolate injection in Simplist prefilled syringes has been made available in the U.S. The Fresenius Kabi Simplist Glycopyrrolate injection, USP, represents the most recent manufacturer-prepared product available in the company’s proprietary, ready-to-administer portfolio of Simplist prefilled syringes, which the company designed to reduce the amount of time nurses spend […]
ADA, DaVita launch interactive digital education resource
The American Diabetes Association (ADA) and DaVita today announced the joint launch of an interactive digital experience. ADA and DaVita’s offering aims to help those living with diabetes to prevent and manage kidney disease. ADA launched the new kidney care education section under “Living with Diabetes” on its website in an effort to provide the […]
ICU Medical’s Smiths Medical has a Class I infusion pump recall
The FDA has issued a notice classifying a recall of infusion pumps from Smiths Medical as Class I, the most serious kind. Smiths Medical — which was acquired by ICU Medical in January for $2.35 billion — earlier this month issued a warning in Europe for the same reason: eight potential issues with its Medfusion […]
AbbVie enters partnership with iStar with option to acquire
AbbVie (NYSE:ABBV) announced today that it entered into a strategic alliance with iStar Medical over the MINIject device. The strategic transaction centers around helping to further develop and commercialize iStar’s MINIject minimally invasive glaucoma surgical (MIGS) device. It will also provide AbbVie with a chance to expand its eye care business through an option to […]
MIT researchers think microparticles could deliver ‘self-boosting’ vaccines
MIT researchers are touting microparticles that can deliver payloads at different points, potentially creating “self-boosting” vaccines. A new study, highlighted on the institute’s news website, demonstrates a way in which researchers could design vaccines that would need to be given just once before they “self-boost,” or essentially re-deliver the therapeutic, at a specified point in […]
Study backs One Drop’s AI-powered blood glucose forecasts in diabetes outcomes
One Drop announced today that a study of its AI-powered blood glucose forecasting technology leads to improved diabetes outcomes. New York-based One Drop published outcomes from a retrospective cohort study in the Journal of Medical Internet Research (JMIR). The study focused on indicators of glycemic control and health data logging in adults with type 2 diabetes using […]
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With […]
UnitedHealthcare to eliminate out-of-pocket costs on insulin, other prescription drugs
UnitedHealthcare announced today that it will eliminate out-of-pocket costs in standard fully insured group plans for certain prescription drugs. Insulin, among a number of drugs used to treat emergencies including severe allergic reactions, hypoglycemia, opioid overdoses, and acute asthma attacks will be included in the new standard offering. Along with insulin, epinephrine (for severe allergic […]
